Here are the 10-K annual reports from Axcelis Technologies Inc (ACLS) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow ACLS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACLS filings page.
Axcelis Technologies reports 2025 revenue of $839.0 million, down from $1,017.9 million in 2024, as the cyclical semiconductor capital equipment market softened. Systems revenue fell to $571.0 million, while gross margin held essentially steady at 44.9% versus 44.7%.
Operating profit declined to $119.3 million and net income to $120.2 million, reflecting lower volumes despite stable profitability per dollar of sales. Aftermarket CS&I revenue grew to $268.0 million, or 31.9% of total revenue, highlighting a larger recurring service base. Systems backlog was $457.0 million at year-end, below $645.8 million in 2024.
The company remains focused on ion implantation, competing mainly with Applied Materials and several Asian rivals, and faces elevated U.S. export-control risk around Chinese customers. Axcelis also outlines risks and terms of its planned all‑stock merger with Veeco, including a fixed 0.3575 exchange ratio for Veeco shares and required regulatory approvals.